Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Internet Bookkeeping Programming for Consultants - 2Vote in favor of the handheld vacuum that you love for its strong attractions!
- 3Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
- 4Most loved Seared Chicken: Which Chain Rules?
- 5Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats
- What’s the shadowy organisation taking Gaza Palestinians to South Africa?
- Brazil judge orders government to add JBS subsidiary to 'dirty list' for slavery
- Family-Accommodating Snow Sports Experiences
- Expert advice for new stargazers: How to begin your amateur astronomy journey
- Instructions to Pick the Right Toothbrush for Your Teeth
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
- Dramatic Dominance d: A Survey of \Feelings in front of an audience\ Theater Play
- Top 10 Smash hit Computer games of the Year
- Figure out How to Pick the Right Dental specialist for Your Dental Inserts
